How have the shares performed?
Lucira Health Inc. (LHDX) saw downtrend of -16.11% in the recent trading with $5.00 being its most recent. The current price level -86.84% lower than the highest price of $37.99 marked by the stock while trading over the past 52-weeks, whereas it is 18.20% higher than the lowest price of $4.23 the company dropped to over past 52-weeks. The latest news story on LHDX appeared in GlobeNewswire under the title “Lucira Health Announces First Quarter 2021 Financial Results” on May-13-21.
Squeezing the time span to 30 day period shows us the stock is currently trading -45.41% below one month high and is +18.20% above of the lowest during that time. Looking into the simple moving average, Lucira Health Inc. (LHDX)’s stock stands at a SMA-50 of $9.78 while that of 5-day is reading $5.59.
Do analysts rate it as a buy, sell or hold?
Irrespective of recent performance, what’s important is what the future holds. In uncertain economic times, a clear picture is difficult to get. Analysts generally have a good understanding of the market works, which gives them a leg up in making predictions. Currently, the stock has been recommended as Hold by 3 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 3.00 for the stock.
Lucira Health Inc. Earnings – What Happened With LHDX
Coming around sales and income figures, publically trading companies under normal circumstances post earnings and revenues near to average estimates by the Wall Street analysts, but those could came either above or below estimates and known as surprise factor. Lucira Health Inc. (LHDX) last released financial results for the quarter that ended 3/30/2021, posting a surprise factor of -63.60% for net revenue. During the reported three-month period, company’s sales were $269.0 million while analysts on average were estimating the same to be $8.0 million.
LHDX – Lucira Health Inc. Stock Earnings Estimates
The perspective of Lucira Health Inc. (NASDAQ:LHDX)’s current quarter earnings identifies that analysts are in consensus over the estimate of -0.33 for stock’s EPS in the current quarter. 3 analysts covering the stock at Wall Street were agreed upon that EPS consensus. Company’s EPS for the last quarter was -0.54.
Investors get the exact data about the key information of institutional ownership in a listed company through its 13F filings at the Stock Exchange Commission (SEC). The total number of common shares currently owned by the public is 45.94 million. LHDX does have institutional investors; and they hold 42.20% of the stock.
Lucira Health Inc. – Insider Activity and Holdings
As on Mar 30, 2021, EPIQ Capital Group, LLC was the top most holder in Lucira Health Inc. (NASDAQ:LHDX) with an ownership of 13.23 million shares of the company or 34.34% of the stake worth $160.13 million. The filing also reveals Federated Hermes, Inc. as the second largest holder in the company with a control over 1.49% of the outstanding shares. Its stake is worth $6.95 million for having 0.57 million shares in hand.
Blackrock Inc. also came holding a key position in the company during the recent quarter and it now holds 1.22% of the outstanding shares. With this there are now 49 institutions which have possession in LHDX’s shares.
Currently, the stock has been recommended as Hold by 3 of the brokerage firms. Analyst ratings are often compiled into a single score from 1 to 5. The score of 1 signifies buy or strong buy, the score of 2 signifies outperform, the score of 3 means hold, and the score of 4 indicates underperform. The simple numeric range of brokerage firm referenced at the scale of 1 to 5 reads a current average recommendation of 3.00 for the stock.